Trial ID or NCT#

NCT02036970

Status

NOT RECRUITING

Purpose

This study assesses the safety and efficacy of bardoxolone methyl relative to placebo in patients with pulmonary arterial hypertension to determine the recommended dose range and evaluate the change from baseline in 6-minute walk distance (6MWD) following 16 weeks of study participation.

Investigator(s)

Roham Zamanian, MD

Contact us to find out if this trial is right for you.

CONTACT

Val Scott
(650) 725-9861